Dermal Toxicity Testing Market to Grow with a CAGR of 8.17% through 2028
Rising
emphasis on consumer product and medicine safety as well as the requirement to
screen prospective therapeutic targets in the early stages of drug development are
expected to drive the Global Dermal Toxicity Testing Market growth in the
forecast period, 2024-2028.
According
to TechSci Research report, “Dermal Toxicity Testing Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028F”, Global Dermal Toxicity Testing Market stood at USD 1.81
Billion in 2022 and is anticipated to project robust growth in the forecast
period with a CAGR of 8.17% through 2028. The market for Dermal Toxicity
Testing devices has witnessed consistent growth over the Rising Demand for
Targeted Drug Delivery. The Increasing investment by public and private
agencies for the development of in-vitro test techniques, increasing demand for
cost-effective and safer alternatives to animal testing in the cosmetics, food,
and pharmaceutical sectors will further drive the growth of Global Dermal
Toxicity Testing market during the forecast period. In-vitro toxicology assays
for evaluating dermal toxicity are cost-reliable, simple, and highly effective
rather than animal testing. Advancements in human cell culture exposure enabled
the development of in-vitro assay systems, which are demonstrative, highly
predictive, and well-suited for toxicity screening of a wide range of chemicals.
Moreover, several efforts by key market players for the development of novel toxicity
testing method are expected to boost market growth. Generic drugs have enormous
demand of assays for toxicology testing. The ongoing research and development
for new drugs and a candidate drug pipeline are expected to spur the demand for
in-vitro testing methods. Cytotoxicity is used for pharmaceutical drug testing
by screening technology prior to the use of any other toxicology testing.
Also,
the high cost of testing and lack of skilled professionals can hamper the
growth of Global Dermal Toxicity Testing Market. Similarly, validation of
alternative methods can restrain the growth of Global Dermal Toxicity Testing
Market. Additionally, regulatory complexity related will further restrict the
growth of Global Dermal Toxicity Testing Market.
Browse
over xx market data Figures spread through xx Pages and an in-depth TOC on
"Global Dermal Toxicity Testing Market.”
Global
Dermal Toxicity Testing Market is segmented into Test Type, Testing Method Type,
End user and Region.
Based on Test Type, Global Dermal Toxicity Testing
market is divided into Skin Irritation Tests, Skin Sensitization Tests. The Skin
Irritation Tests segment accounted for the largest revenue share in 2022 and is
expected to exhibit a rapid CAGR over the forecast period. This can be
attributed to the due to prominently rising awareness of potential risks
associated with substances applied to the skin. Also, strong demand for comprehensive dermal toxicity test services, ensuring
the safety of consumers and introducing new chemical entities and products will
further propel the growth of Global Dermal Toxicity Testing Market
during the forecast period. The dermal toxicity market growth is also
fueled by advancements in testing technologies, which have transformed the
field of dermal toxicity assessment.
Major
companies operating in Global Dermal Toxicity Testing Market
are:
- SGS
S.A.
- Covance,
Inc
- Bio-Rad
Laboratories Inc.
- Qiagen
N.V.
- GE
Healthcare
- Eurofins
Scientific Inc
- Merck
KgaA
- Thermo
Fisher Scientific, Inc.
- Charles
River Laboratories International, Inc.
- Catalent,
Inc.
In 2021-May: GE Healthcare
took over Zionexa, a leading innovator of in-vivo oncology and neurology
biomarkers. Through this acquisition, Zionexa would propel the growth of its
encouraging R&D pipeline along with its business footprint, while
delivering Zionexa’s employees’ access to global and integral expertise.
In March 2022, Virpax
completed all necessary pre-clinical studies, including dermal toxicity, for
their investigational topical spray analgesic product, Epoladerm. This product
aims to manage chronic pain associated with knee osteoarthritis, potentially
relieving patients.
In January 2021, EPA
finalizing guidance to waive animal skin toxicity tests further promotes the
use of alternative methods in dermal toxicity assessment and reduces reliance
on animal testing.
Download
Free Sample Report
Customers can also request for 10% free
customization on this report.
“The North America region is expected to
witness significant growth of Global Dermal Toxicity Testing market owing to
the sophisticated healthcare infrastructure, supportive government regulations,
the increasing presence of prominent market players, advanced infrastructure
& shifting focus on drug discovery in the region. Technological
advancements and increasing adoption of in-vitro testing methods in the region
also act as drivers for the growth of in-vitro toxicology testing market. The
launch of biologics by biopharmaceutical players in the United States has
resulted in the rapid adoption of toxicology testing. The expansion of laboratory
capabilities in the region has enabled clients to build toxicological profiles
of biopharmaceuticals, medical devices, chemicals, and cosmetics Brands that
prioritize responsible testing practices gain consumer trust and loyalty. As
public awareness of ethical considerations rises, companies are motivated to
adopt advanced, non-animal testing methods which is the major factor driving
the growth of the global Dermal Toxicity Testing Market during the forecast
period” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Dermal Toxicity
Testing Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Test Type (Skin Irritation Tests, Skin Sensitization
Tests), By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In
Vitro Testing (Cell-Based or Tissue-Based Tests), By End User (Pharmaceuticals
industries, Cosmetics and personal care products industry, Chemical Industry
and Other), By Region and Competition”,
has evaluated the future growth potential of Global Dermal Toxicity Testing Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Dermal Toxicity Testing Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com